Status:
NOT_YET_RECRUITING
PCA Administration in Prosthetic Joint Infection
Lead Sponsor:
Dr. Dean Reeves Clinic
Collaborating Sponsors:
Lanny Johnson, M.D.
Leo Whiteside, M.D.
Conditions:
Prosthetic Joint Infection
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Determine if dietary protocatechuic acid (PCA) will affect health biomarkers in patient undergoing revision surgery for a knee prosthetic joint infection
Detailed Description
Patients who are scheduled to undergo revision surgery for a knee prosthetic joint infection are given PCA prior to surgery for a time period determined by a previous pilot study. PCA is then post-ope...
Eligibility Criteria
Inclusion
- 3 weeks or more after total knee arthroplasty
- One or more symptoms of infection, including redness, swelling, pain, increasing range of motion loss, fever, nausea, and loss of appetite.
- WBC count of aspirate \>50,000 cells per μL
Exclusion
- Not willing to undergo blood draw at 3 months.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06591741
Start Date
January 1 2026
End Date
December 1 2028
Last Update
August 20 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.